John Schieffelin is an Infectious Disease physician affiliated with Tulane University. OpenAlex indexes 194 publications with 26,164 citations (h-index 37); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
275 Lasalle St
Hc-57
New Orleans, LA 701122615
Telephone
504-988-5030Registry record last updated 9 Jan 2012.
Clinical trials
- REVIVE (Response to the Ebola Virus Vaccine)
Sponsor: Tulane University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20241 payment
- CepheidProgram year20241 payment
- ViiV Healthcare CompanyProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
51%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor20.6%Triumeq100%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor8.2%Lamivudine-Zidovudine100%Part D<11 patients+ 3 more classes in this area
Nervous system
23.2%Gabapentinoids10.3%Gabapentin100%Part D<11 patientsSSRI6.7%Sertraline Hcl100%Part D<11 patients+ 1 more class in this area
Cardiovascular
10.3%Statin10.3%Pravastatin Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
Tulane University of Louisiana
FY2026$172,565D43TW011248 - Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
Tulane University of Louisiana
FY2026$81,724D43TW011248 - Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
Tulane University of Louisiana
FY2026$42,880D43TW011248
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study
PLoS neglected tropical diseases
2023 - Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola
Clinical Infectious Diseases
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Erik Castle, MD
Tulane University
Thierry Lejemtel, MD
Tulane University
Robert Hendel, MD
Tulane University
Vecihi Batuman, MD
Tulane University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”